WARWICKSHIRE medtech firm Mediwatch has said it remains on course to meet market expectations after a programme of rationalisation and cost savings helped to stabilise the firm during the first half.The Rugby company, which develops a range of medical equipment for the diagnosis of urological disorders, saw H1 group turnover reach £5.084m (H1 2011: £5.095 million) with revenue split 50/50 between the US and the UK, Europe and the rest of world (ROW). The product mix was similar to that seen in the H1 period last ye......for the full story register now for free or login below...